Fabrice Bartolomei Selected Research

Fabrice Bartolomei Research Topics

Disease

32	Epilepsy (Aura) 04/2024 - 10/2012
26	Drug Resistant Epilepsy 03/2024 - 02/2004
23	Seizures (Absence Seizure) 12/2023 - 02/2004
9	Partial Epilepsies (Epilepsy, Partial) 04/2024 - 06/2007
6	Temporal Lobe Epilepsy 01/2023 - 10/2002
3	Amnesia (Dissociative Amnesia) 01/2023 - 05/2014
3	Status Epilepticus (Complex Partial Status Epilepticus) 01/2019 - 04/2009
2	Epileptic Syndromes 01/2023 - 05/2014
2	Syncope (Fainting) 01/2023 - 06/2020
2	Tuberous Sclerosis (Bourneville's Disease) 01/2022 - 01/2020
2	Spasm (Spasms) 01/2022 - 11/2014
2	Hypoxia (Hypoxemia) 01/2019 - 11/2016
2	Anxiety Disorders (Anxiety Disorder) 01/2018 - 03/2017
2	Nervous System Diseases (Neurological Disorders) 03/2017 - 03/2015
2	Focal Cortical Dysplasia 01/2016 - 11/2009
2	Wounds and Injuries (Trauma) 10/2012 - 08/2005
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 06/2023
1	Neurodevelopmental Disorders 12/2021
1	Brain Diseases (Brain Disorder) 12/2021
1	Malformations of Cortical Development 12/2020
1	Hypertrophy 10/2020
1	Hypothalamic hamartomas 01/2020
1	Herpes Simplex Encephalitis (Herpes Encephalitis) 01/2019
1	Fever (Fevers) 01/2019
1	Depressive Disorder (Melancholia) 01/2018
1	Infantile Spasms (West Syndrome) 01/2017
1	Apnea 11/2016
1	Sudden Unexpected Death in Epilepsy 11/2016
1	Coma (Comas) 11/2016
1	Pain (Aches) 11/2016
1	Treatment-Resistant Depressive Disorder 07/2016
1	Encephalitis (Encephalitis, Rasmussen) 01/2016
1	Disease Progression 11/2015
1	Dysthymic Disorder 03/2015
1	Aphasia (Dysphasia) 08/2014
1	Cavernous Hemangioma (Cavernous Angioma) 05/2014
1	Inflammation (Inflammations) 10/2012
1	Periventricular Nodular Heterotopia 01/2008

Drug/Important Bio-Agent (IBA)

3	Anticonvulsants (Antiepileptic Drugs)IBA 04/2023 - 01/2017
3	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2017
3	SodiumIBA 01/2023 - 01/2017
3	trans-sodium crocetinate (crocetin)IBA 01/2022 - 01/2017
3	Complement System Proteins (Complement)IBA 11/2015 - 02/2004
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 11/2023 - 01/2023
2	Protons (Proton)IBA 01/2023 - 10/2002
2	TeaIBA 01/2023 - 05/2014
2	Kainic Acid (Kainate)IBA 01/2019 - 06/2012
2	3,4-methylenedioxyethamphetamine (MDEA)IBA 03/2017 - 03/2015
2	Pilocarpine (Ocusert)FDA LinkGeneric 06/2012 - 04/2009
1	amsonic acid (DAS)IBA 01/2023
1	Coffee FDA Link 01/2022
1	TESIBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 12/2021
1	NADP (NADPH)IBA 12/2021
1	Potassium Channels (Potassium Channel)IBA 12/2021
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 12/2020
1	SR-ATIBA 10/2020
1	tempolIBA 01/2019
1	Oxygen (Dioxygen)IBA 01/2019
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2019
1	Explosive Agents (Explosives)IBA 09/2017
1	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2017
1	Lacosamide FDA Link 01/2017
1	Naltrexone (ReVia)FDA LinkGeneric 11/2016
1	Narcotic Antagonists (Opioid Antagonists)IBA 11/2016
1	Naloxone (Narcan)FDA LinkGeneric 11/2016
1	Opioid Analgesics (Opioids)IBA 11/2016
1	Adalimumab (Humira)FDA Link 01/2016
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2016
1	MTOR InhibitorsIBA 11/2015
1	TOR Serine-Threonine KinasesIBA 11/2015
1	ChromatinIBA 11/2015
1	CalciumIBA 10/2015
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 10/2012
1	PlasticsIBA 08/2005

Therapy/Procedure

30	Electrodes (Electrode) 03/2024 - 10/2002
9	Therapeutics 11/2023 - 01/2016
8	Deep Brain Stimulation 01/2023 - 07/2016
4	Electrocoagulation (Electrocautery) 04/2024 - 01/2019
4	Vagus Nerve Stimulation 04/2023 - 07/2015
4	Psychology Biofeedback (Biofeedback) 01/2021 - 12/2014
2	Transcranial Direct Current Stimulation 01/2022 - 01/2022
1	Implanted Electrodes 08/2022
1	Perioperative Period 02/2022
1	Transcranial Magnetic Stimulation 01/2021
1	Operative Surgical Procedures 01/2021
1	Transjugular Intrahepatic Portasystemic Shunt 01/2020
1	Injections 01/2019
1	Contraindications 01/2019
1	Intravenous Injections 11/2016
1	Oral Administration 11/2016
1	Ketogenic Diet 11/2015